Literature DB >> 20940054

Immunoaffinity purification of polyepitope proteins against Plasmodium falciparum with chicken IgY specific to their C-terminal epitope tag.

Jiu-xin Qu1, Ya-hui Lin, Rui-sen Ma, Heng Wang.   

Abstract

Developing a polyepitope vaccine, a chimeric protein which contains diverse types of antigenic epitopes, is a promising strategy to prevent malaria. Previously, we had constructed a library of polyeptitope chimeric genes against Plasmodium falciparum without any protein tags. In an attempt to develop an efficient and universal procedure for purification of polyepitope chimeric proteins, we assembled an immunoaffinity chromatography (IAC) column with affinity-purified specific polyclonal IgY (mpIgY) antibodies that recognized the same C-terminal epitope tag of chimeric proteins in the library. A single-step and universal protocol was established and successfully applied for the purification of chimeric proteins. Using this protocol, chimeric proteins were specifically purified from an Escherichia coli expression system, and the purity and authenticity were verified by gel electrophoresis and Western blot analysis. Moreover, the comparison between this IAC method and the conventional chromatography, using two anion exchange columns followed by a step of gel filtration, showed that the new method was more efficient with an 8-fold greater yield. The results suggest that this IAC method will be an efficient approach for the purifications of polyepitope vaccine candidates against P. falciparum in our future study, and also be valuable for other similar applications. Crown
Copyright © 2010. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20940054     DOI: 10.1016/j.pep.2010.10.003

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  1 in total

1.  Production, characterization and applications for Toxoplasma gondii-specific polyclonal chicken egg yolk immunoglobulins.

Authors:  Álvaro Ferreira Júnior; Fernanda M Santiago; Murilo V Silva; Flávia B Ferreira; Arlindo G Macêdo Júnior; Caroline M Mota; Matheus S Faria; Hercílio H Silva Filho; Deise A O Silva; Jair P Cunha-Júnior; José R Mineo; Tiago W P Mineo
Journal:  PLoS One       Date:  2012-07-12       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.